Carol Giltner Gallagher - 04 Nov 2022 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Director
Signature
/s/ Winston Kung, by power of attorney
Issuer symbol
PMVP
Transactions as of
04 Nov 2022
Net transactions value
$0
Form type
4
Filing time
08 Nov 2022, 15:22:36 UTC
Previous filing
08 Nov 2022
Next filing
23 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Award $0 +39,000 $0.000000 39,000 04 Nov 2022 Common Stock 39,000 $11.28 Direct F1
transaction PMVP Stock Option (right to buy) Gift $0 -39,000 -50% $0.000000 39,000 05 Nov 2022 Common Stock 39,000 $11.28 Direct F1
transaction PMVP Stock Option (right to buy) Gift $0 +39,000 $0.000000 39,000 05 Nov 2022 Common Stock 39,000 $11.28 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest in 36 equal, monthly installments beginning on December 4, 2022.
F2 The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee.